Your browser doesn't support javascript.
loading
Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.
Koiwa, Fumihiko; Yokoyama, Keitaro; Fukagawa, Masafumi; Terao, Akira; Akizawa, Tadao.
Afiliação
  • Koiwa F; Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Yokoyama K; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
  • Terao A; Biostatistics, Faculty of Pharmaceutical Sciences, Josai University, Sakado, Japan.
  • Akizawa T; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Nephrology (Carlton) ; 22(4): 293-300, 2017 Apr.
Article em En | MEDLINE | ID: mdl-27496336

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fósforo / Sacarose / Compostos Férricos / Quelantes / Diálise Renal / Insuficiência Renal Crônica / Hiperfosfatemia / Sevelamer Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fósforo / Sacarose / Compostos Férricos / Quelantes / Diálise Renal / Insuficiência Renal Crônica / Hiperfosfatemia / Sevelamer Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article